Catalysts for Change: The Role of Nonprofits in Solving Single Ventricle Heart Disease
2. SV Incidence and Outcomes
3. Economic Burden of SV
4. Funding Landscape
5. Research Landscape
6. SV: A Model for Innovative Investment
7. Nonprofits: Catalysts for Change
- Significant co-morbidities: The Fontan circulation results in chronic elevation in venous pressure and decreased cardiac output which predisposes SV patients to many co-morbidities, including circulatory failure, ventricular dysfunction, atrioventricular valve regurgitation, arrhythmia, protein losing enteropathy, plastic bronchitis, liver fibrosis, and renal dysfunction .
- Neurodevelopmental disabilities: Although surgical outcomes have improved for those with cCHDs, neurological outcomes have not . A review of studies around the neurodevelopmental outcomes of children with CHDs found that those with cCHDs were at significantly elevated risk for developmental delays in intelligence, academic achievement, language, visual construction and perception, attention, executive functioning, fine motor skills, gross motor skills, and psychosocial maladjustment . Executive dysfunction increases with the severity of CHD .
- Economic burden on parents and caregivers: Financial burdens are more common among families with a child with CHD than families who have children with other types of special health needs . A survey of US households from 2011 to 2017 that included nearly 200 families living with CHD found that nearly half of these families reported experiencing some level of financial hardship due to their child’s medical bills; 17% stated they could not pay their medical bills at all 
- Economic burden on adult patients: Studies have found an employment rate of only 47% for adults with cCHDs [15,29]. Adults with cCHDs are more likely than those with less severe forms of CHD to have household incomes below USD 50,000 . The total burden of CHD has been estimated at USD 500,000 per adult when considering medical costs and decreased earnings .
Conflicts of Interest
- Hoffman, J.I.E.; Kaplan, S. The Incidence of Congenit. Heart Disease. J. Am. Coll. Cardiol. 2002, 39, 1890–1900. [Google Scholar] [CrossRef][Green Version]
- Heaton, J.; Heller, D. Single Ventricle. In Consults in Obstetric Anesthesiology; Springer: Cham, Switzerland, 2021; pp. 535–536. [Google Scholar] [CrossRef]
- Rao, P.S. Single Ventricle—A Comprehensive Review. Children 2021, 8, 441. [Google Scholar] [CrossRef] [PubMed]
- Fontan, F.; Baudet, E. Surgical Repair of Tricuspid Atresia. Thorax 1971, 26, 240–248. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Rychik, J.; Atz, A.M.; Celermajer, D.S.; Deal, B.J.; Gatzoulis, M.A.; Gewillig, M.H.; Hsia, T.-Y.; Hsu, D.T.; Kovacs, A.H.; McCrindle, B.W.; et al. Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association. Circulation 2019, 140, e234–e284. [Google Scholar] [CrossRef] [PubMed]
- Life after Fontan Palliation—Mayo Clinic. Available online: https://www.mayoclinic.org/medical-professionals/cardiovascular-diseases/news/life-after-fontan-palliation/mac-20430343 (accessed on 22 March 2022).
- Gilboa, S.M.; Devine, O.J.; Kucik, J.E.; Oster, M.E.; Riehle-Colarusso, T.; Nembhard, W.N.; Xu, P.; Correa, A.; Jenkins, K.; Marelli, A.J. Congenital Heart Defects in the United States: Estimating the Magnitude of the Affected Population in 2010. Circulation 2016, 134, 101–109. [Google Scholar] [CrossRef] [PubMed][Green Version]
- McClung, N.; Glidewell, J.; Farr, S.L. Financial Burdens and Mental Health Needs in Families of Children with Congenital Heart Disease. Congenital Heart Disease 2018, 13, 554–562. [Google Scholar] [CrossRef] [PubMed]
- NCBDDD: Improving the Health of People Across the Lifespan. Available online: https://www.cdc.gov/ncbddd/heartdefects/documents/chd-improving-lifespan-health-factsheet.html (accessed on 22 March 2022).
- Limperopoulos, C.; Majnemer, A.; Shevell, M.I.; Rosenblatt, B.; Rohlicek, C.; Tchervenkov, C. Neurodevelopmental Status of Newborns and Infants with Congenital Heart Defects before and after Open Heart Surgery. J. Pediatr. 2000, 137, 638–645. [Google Scholar] [CrossRef] [PubMed]
- Shillingford, A.J.; Glanzman, M.M.; Ittenbach, R.F.; Clancy, R.R.; Gaynor, J.W.; Wernovsky, G. Inattention, Hyperactivity, and School Performance in a Population of School-Age Children with Complex Congenital Heart Disease. Pediatrics 2008, 121, e759–e767. [Google Scholar] [CrossRef] [PubMed]
- Miller, A.; Riehle-Colarusso, T.; Alverson, C.J.; Frías, J.L.; Correa, A. Congenital Heart Defects and Major Structural Noncardiac Anomalies, Atlanta, Georgia, 1968 to 2005. J. Pediatr. 2011, 159, 70–78. [Google Scholar] [CrossRef] [PubMed]
- Girouard, H.S.; Kovacs, A.H. Congenital Heart Disease: Education and Employment Considerations and Outcomes. Int. J. Cardiol. Congenit. Heart Dis. 2020, 1, 100005. [Google Scholar] [CrossRef]
- Chambers, J.G.; Shkolnik, J. Total Expenditures for Students with Disabilities, 1999–2000: Spending Variation by Disability Special Education Expenditure Project. Available online: https://www.air.org/sites/default/files/SEEP5-Total-Expenditures.pdf (accessed on 22 March 2022).
- Pfitzer, C.; Helm, P.C.; Rosenthal, L.M.; Walker, C.; Ferentzi, H.; Bauer, U.M.M.; Berger, F.; Schmitt, K.R.L. Educational Level and Employment Status in Adults with Congenital Heart Disease. Cardiol. Young 2018, 28, 32–38. [Google Scholar] [CrossRef] [PubMed]
- Gong, C.L.; Zhao, H.; Wei, Y.; Tysinger, B.; Goldman, D.P.; Williams, R.G. Lifetime Burden of Adult Congenital Heart Disease in the USA Using a Microsimulation Model. Pediatr. Cardiol. 2020, 41, 1515–1525. [Google Scholar] [CrossRef] [PubMed]
- Frese; Lewin, K. The National Economic Burden of Rare Diseases Study. 2021. Available online: https://everylifefoundation.org/wp-content/uploads/2021/02/The_National_Economic_Burden_of_Rare_Disease_Study_Summary_Report_February_2021.pdf (accessed on 21 March 2022).
- Ludomirsky, A.B.; Bucholz, E.M.; Newburger, J.W. Association of Financial Hardship Because of Medical Bills with Adverse Outcomes Among Families of Children with Congenital Heart Disease. JAMA Cardiol. 2021, 6, 713–717. [Google Scholar] [CrossRef] [PubMed]
- The Alzheimer’s Disease Crisis—By the Numbers|Us Against Alzheimer’s. Available online: https://www.usagainstalzheimers.org/learn/alzheimers-crisis (accessed on 22 March 2022).
- RePORT. Available online: https://report.nih.gov/funding/categorical-spending#/ (accessed on 22 March 2022).
- Burns, K.M.; Pemberton, V.L.; Schramm, C.A.; Pearson, G.D.; Kaltman, J.R. Trends in National Institutes of Health-Funded Congenital Heart Disease Research from 2005 to 2015. Pediatr. Cardiol. 2017, 38, 974. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Additional Ventures 2021 Annual Report: Solving Single Ventricle. Available online: https://32nqsf43iu0f6y1de2ax69yu-wpengine.netdna-ssl.com/wp-content/uploads/2021/10/AV_Annual_Report_r6v1_FINAL_Single-Page_10.19.21.pdf (accessed on 22 March 2022).
- Roadmap to Solving Single Ventricle Heart Disease Additional Ventures. Available online: https://www.additionalventures.org/initiatives/biomedical-research/research-roadmap/ (accessed on 22 March 2022).
- Giusti, K.; Hamermesh, R.G. How Nonprofit Foundations Can Sustainably Fund Disease Research. Available online: https://hbr.org/2020/09/how-nonprofit-foundations-can-sustainably-fund-disease-research (accessed on 22 March 2022).
- Nonprofits Role in Drug Development | Milken Institute. Available online: https://milkeninstitute.org/report/nonprofits-growing-force-drug-development (accessed on 28 March 2022).
- Gaynor, J.W.; Stopp, C.; Wypij, D.; Andropoulos, D.B.; Atallah, J.; Atz, A.M.; Beca, J.; Donofrio, M.T.; Duncan, K.; Ghanayem, N.S.; et al. Neurodevelopmental Outcomes after Cardiac Surgery in Infancy. Pediatrics 2015, 135, 816–825. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Marino, B.S.; Lipkin, P.H.; Newburger, J.W.; Peacock, G.; Gerdes, M.; Gaynor, J.W.; Mussatto, K.A.; Uzark, K.; Goldberg, C.S.; Johnson, W.H.; et al. Neurodevelopmental Outcomes in Children with Congenital Heart Disease: Evaluation and Management a Scientific Statement from the American Heart Association. Circulation 2012, 126, 1143–1172. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Cassidy, A.R.; White, M.T.; DeMaso, D.R.; Newburger, J.W.; Bellinger, D.C. Executive Function in Children and Adolescents with Critical Cyanotic Congenital Heart Disease. J. Int. Neuropsychol. Soc. 2015, 21, 34. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Karsenty, C.; Maury, P.; Blot-Souletie, N.; Ladouceur, M.; Leobon, B.; Senac, V.; Mondoly, P.; Elbaz, M.; Galinier, M.; Dulac, Y.; et al. The Medical History of Adults with Complex Congenital Heart Disease Affects Their Social Development and Professional Activity. Arch. Cardiovasc. Dis. 2015, 108, 589–597. [Google Scholar] [CrossRef] [PubMed][Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Davis, K.A.; Pickles, D.M.; Keller, K.E. Catalysts for Change: The Role of Nonprofits in Solving Single Ventricle Heart Disease. J. Cardiovasc. Dev. Dis. 2022, 9, 220. https://doi.org/10.3390/jcdd9070220
Davis KA, Pickles DM, Keller KE. Catalysts for Change: The Role of Nonprofits in Solving Single Ventricle Heart Disease. Journal of Cardiovascular Development and Disease. 2022; 9(7):220. https://doi.org/10.3390/jcdd9070220Chicago/Turabian Style
Davis, Kaitlin A., Diane M. Pickles, and Kirstie E. Keller. 2022. "Catalysts for Change: The Role of Nonprofits in Solving Single Ventricle Heart Disease" Journal of Cardiovascular Development and Disease 9, no. 7: 220. https://doi.org/10.3390/jcdd9070220